|
Diabetes Care, Vol 20, Issue 9 1363-1367, Copyright © 1997 by American Diabetes Association
ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside, Scotland. Medicines Monitoring Unit
AD Morris, DI Boyle, AD McMahon, H Pearce, JM Evans, RW Newton, RT Jung and TM MacDonald
Department of Medicine, Ninewells Hospital and Medical School, University of Dundee, Scotland, U.K. amorris@clinpharm.dundee.ac.uk
OBJECTIVE: To evaluate the association between the use of ACE inhibitors
and hospital admission for severe hypoglycemia and to explore the effects
of potential confounding variables on this relationship. RESEARCH DESIGN
AND METHODS: The association between the use of ACE inhibitors and the
incidence of hypoglycemia is controversial. A recent study reported that
14% of all hospital admissions for hypoglycemia might be attributable to
ACE inhibitors. We performed a nested case-control study, using a cohort of
6,649 diabetic patients taking insulin or oral antidiabetic drugs, on the
Diabetes Audit and Research in Tayside, Scotland (DARTS) database. From 1
January 1993 to 30 April 1994, we identified 64 patients who had been
admitted to Tayside hospitals with hypoglycemia and selected 440 control
patients from the same cohort. RESULTS: Hypoglycemia was associated with
the use of ACE inhibitors (odds ratio [OR] 3.2, 95% CI 1.2-8.3, P = 0.023),
whereas use of beta-blockers and calcium antagonists was not associated
with an increased risk of hospitalization for hypoglycemia with ORs of 0.9
(95% CI 0.3-3.3) and 1.7 (95% CI 0.2-2.1), respectively. There were
significant differences between case and control patients in type of
diabetes treatment, diabetes duration, place of routine diabetes care, and
congestive cardiac failure. These differences did not confound the
relationship between ACE inhibitors and hypoglycemia (adjusted OR 4.3, 95%
CI 1.2-16.0). CONCLUSIONS: The results show that the association between
ACE inhibitor therapy and hospital admission for severe hypoglycemia is not
explained by these confounding factors. Although ACE inhibitors have
distinct advantages over other antihypertensive drugs in diabetes, the risk
of hypoglycemia should be considered.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Ginde, D. J. Pallin, and C. A. Camargo Jr
Hospitalization and Discharge Education of Emergency Department Patients With Hypoglycemia
The Diabetes Educator,
July 1, 2008;
34(4):
683 - 691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. MacDonald, M. C. Petrie, N. M. Hawkins, J. R. Petrie, M. Fisher, R. McKelvie, D. Aguilar, H. Krum, and J. J.V. McMurray
Diabetes, left ventricular systolic dysfunction, and chronic heart failure
Eur. Heart J.,
May 2, 2008;
29(10):
1224 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Pedersen-Bjergaard, C. E Thomsen, H. Hogenhaven, A. Smed, T. W Kjaer, J. J Holst, F. Dela, L. Hilsted, E. Frandsen, S. Pramming, et al.
Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans
Journal of Renin-Angiotensin-Aldosterone System,
March 1, 2008;
9(1):
37 - 48.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl.,
June 1, 2007;
9(suppl_C):
C3 - C74.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J.,
January 1, 2007;
28(1):
88 - 136.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. C. Winkelmayer, Z. Zhang, S. Shahinfar, M. E. Cooper, J. Avorn, and B. M. Brenner
Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes
Diabetes Care,
October 1, 2006;
29(10):
2210 - 2217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Lee, J. V. Tu, D. N. Juurlink, D. A. Alter, D. T. Ko, P. C. Austin, A. Chong, T. A. Stukel, D. Levy, and A. Laupacis
Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
JAMA,
September 14, 2005;
294(10):
1240 - 1247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Appel, J. Radhakrishnan, M. M. Avram, R. A. DeFronzo, F. Escobar-Jimenez, M.M. Campos, E. Burgess, D. A. Hille, T. Z. Dickson, S. Shahinfar, et al.
Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study
Diabetes Care,
May 1, 2003;
26(5):
1402 - 1407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nordfeldt and U. Samuelsson
Serum ACE Predicts Severe Hypoglycemia in Children and Adolescents With Type 1 Diabetes
Diabetes Care,
February 1, 2003;
26(2):
274 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bartnik, K. Malmberg, and L. Ryden
Diabetes and the heart: compromised myocardial function -- a common challenge
Eur. Heart J. Suppl.,
January 1, 2003;
5(suppl_B):
B33 - B41.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Gross, T. Zelmanovitz, C. C. Moulin, V. De Mello, M. Perassolo, C. Leitao, A. Hoefel, A. Paggi, and M. J. Azevedo
Effect of a Chicken-Based Diet on Renal Function and Lipid Profile in Patients With Type 2 Diabetes: A randomized crossover trial
Diabetes Care,
April 1, 2002;
25(4):
645 - 651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Petrie, A. D. Morris, S. Ueda, M. Small, R. Donnelly, J. M. C. Connell, and H. L. Elliott
Trandolapril Does Not Improve Insulin Sensitivity in Patients with Hypertension and Type 2 Diabetes: A Double-Blind, Placebo-Controlled Crossover Trial
J. Clin. Endocrinol. Metab.,
May 1, 2000;
85(5):
1882 - 1889.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M M Evans, R. W Newton, D. A Ruta, T. M MacDonald, R. J Stevenson, and A. D Morris
Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database
BMJ,
July 10, 1999;
319(7202):
83 - 86.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. L. Peters and W. Hsueh
Antihypertensive Agents in Diabetic Patients: Great Benefits, Special Risks
Arch Intern Med,
March 22, 1999;
159(6):
541 - 542.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
DO ACE INHIBITORS PROMOTE HYPOGLYCEMIA IN DIABETIC PATIENTS?
Journal Watch (General),
September 16, 1997;
1997(916):
1 - 1.
[Full Text]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|